Browse the detailed record of transactions filed by BJERKHOLT ERIC, 首席财务官. Director active across 5 companies, notably CERUS CORP. Aggregated, 43 reports have been logged. Split: 10 buys · 11 sells. Total volume traded: €1.1m. Activity tracked since 1 June 2022. The latest transaction was disclosed on 6 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Eric Bjerkholt is the Chief Financial Officer and Director at Cerus Corp and Chinook Therapeutics, Inc. In these roles, he is responsible for the financial management of the companies, including financial planning and regulatory compliance. Bjerkholt plays a key role in developing financial strategies and optimizing economic performance. His expertise in finance is crucial for supporting the growth of the companies.